» Articles » PMID: 25982835

Reactive Astrocytes and Therapeutic Potential in Focal Ischemic Stroke

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2015 May 19
PMID 25982835
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes are specialized and the most abundant cell type in the central nervous system (CNS). They play important roles in the physiology of the brain. Astrocytes are also critically involved in many CNS disorders including focal ischemic stroke, the leading cause of brain injury and death in patients. One of the prominent pathological features of a focal ischemic stroke is reactive astrogliosis and glial scar formation. Reactive astrogliosis is accompanied with changes in morphology, proliferation, and gene expression in the reactive astrocytes. This study provides an overview of the most recent advances in astrocytic Ca(2+) signaling, spatial, and temporal dynamics of the morphology and proliferation of reactive astrocytes as well as signaling pathways involved in the reactive astrogliosis after ischemic stroke based on results from experimental studies performed in various animal models. This review also discusses the therapeutic potential of reactive astrocytes in focal ischemic stroke. As reactive astrocytes exhibit high plasticity, we suggest that modulation of local reactive astrocytes is a promising strategy for cell-based stroke therapy.

Citing Articles

Reactive Astrocytes Release GDNF to Promote Brain Recovery and Neuronal Survival Following Ischemic Stroke.

Zhang Z, Zhang N, Ding S Neurochem Res. 2025; 50(2):117.

PMID: 40085335 DOI: 10.1007/s11064-025-04370-6.


Phosphodiesterase 4 inhibition as a novel treatment for stroke.

Zhong J, Yu X, Lin Z PeerJ. 2025; 13:e18905.

PMID: 39897494 PMC: 11786714. DOI: 10.7717/peerj.18905.


Characterisation of GPR17-expressing oligodendrocyte precursors in human ischaemic lesions and correlation with reactive glial responses.

Raffaele S, Clausen B, Mannella F, Wirenfeldt M, Marangon D, Tidgen S J Pathol. 2024; 265(2):226-243.

PMID: 39703181 PMC: 11717493. DOI: 10.1002/path.6381.


Alpha‑Asarone Ameliorates Neuronal Injury After Ischemic Stroke and Hemorrhagic Transformation by Attenuating Blood-Brain Barrier Destruction, Promoting Neurogenesis, and Inhibiting Neuroinflammation.

Luo L, Hu Q, Yan R, Gao X, Zhang D, Yan Y Mol Neurobiol. 2024; 62(4):5252-5272.

PMID: 39531192 DOI: 10.1007/s12035-024-04596-5.


Targeting the neurovascular unit: Therapeutic potential of traditional Chinese medicine for the treatment of stroke.

Wu B, Zhou D, Mei Z Heliyon. 2024; 10(19):e38200.

PMID: 39386825 PMC: 11462356. DOI: 10.1016/j.heliyon.2024.e38200.


References
1.
Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K . Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med. 2006; 12(7):829-34. DOI: 10.1038/nm1425. View

2.
Kang W, Hebert J . Signaling pathways in reactive astrocytes, a genetic perspective. Mol Neurobiol. 2011; 43(3):147-54. PMC: 3087829. DOI: 10.1007/s12035-011-8163-7. View

3.
Nowicka D, Rogozinska K, Aleksy M, Witte O, Skangiel-Kramska J . Spatiotemporal dynamics of astroglial and microglial responses after photothrombotic stroke in the rat brain. Acta Neurobiol Exp (Wars). 2008; 68(2):155-68. DOI: 10.55782/ane-2008-1685. View

4.
Huang Y, Bergles D . Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol. 2004; 14(3):346-52. DOI: 10.1016/j.conb.2004.05.007. View

5.
Ridet J, Malhotra S, Privat A, Gage F . Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1998; 20(12):570-7. DOI: 10.1016/s0166-2236(97)01139-9. View